WO2019090125A2 - Système d'administration de médicament transdermique anti-abus intelligent - Google Patents

Système d'administration de médicament transdermique anti-abus intelligent Download PDF

Info

Publication number
WO2019090125A2
WO2019090125A2 PCT/US2018/059026 US2018059026W WO2019090125A2 WO 2019090125 A2 WO2019090125 A2 WO 2019090125A2 US 2018059026 W US2018059026 W US 2018059026W WO 2019090125 A2 WO2019090125 A2 WO 2019090125A2
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
transdermal drug
delivery device
sensor
gel formulation
Prior art date
Application number
PCT/US2018/059026
Other languages
English (en)
Other versions
WO2019090125A3 (fr
Inventor
Navdeep KAUR
Anubhav Arora
Aofie MULLIGAN
Kevin GELSTON
Original Assignee
Chrono Therapeutics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chrono Therapeutics Inc. filed Critical Chrono Therapeutics Inc.
Publication of WO2019090125A2 publication Critical patent/WO2019090125A2/fr
Publication of WO2019090125A3 publication Critical patent/WO2019090125A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Abstract

Un dispositif d'administration de médicament transdermique comprend un réservoir, une membrane d'administration de médicament transdermique, et un trajet de fluide entre le réservoir et la membrane d'administration de médicament transdermique. Le réservoir comprend une formulation de gel ayant un agoniste opioïde. La membrane d'administration de médicament transdermique est conçue pour entrer en contact avec la peau d'un patient afin de délivrer l'agoniste opioïde sur la peau.
PCT/US2018/059026 2017-11-02 2018-11-02 Système d'administration de médicament transdermique anti-abus intelligent WO2019090125A2 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762580895P 2017-11-02 2017-11-02
US201762580884P 2017-11-02 2017-11-02
US62/580,884 2017-11-02
US62/580,895 2017-11-02
US201862616340P 2018-01-11 2018-01-11
US62/616,340 2018-01-11
US201862732952P 2018-09-18 2018-09-18
US62/732,952 2018-09-18

Publications (2)

Publication Number Publication Date
WO2019090125A2 true WO2019090125A2 (fr) 2019-05-09
WO2019090125A3 WO2019090125A3 (fr) 2020-04-02

Family

ID=66331474

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/059026 WO2019090125A2 (fr) 2017-11-02 2018-11-02 Système d'administration de médicament transdermique anti-abus intelligent

Country Status (1)

Country Link
WO (1) WO2019090125A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
ME02661B (fr) * 2004-02-23 2017-06-20 Euro Celtique Sa Dispositif d'administration transdermique opioïde résistante aux abus
CN101316623A (zh) * 2005-09-30 2008-12-03 Tti优而美株式会社 系统输送活性剂的离子电渗方法和装置
WO2011123866A1 (fr) * 2010-04-02 2011-10-06 Alltranz Inc. Formulations transdermiques empêchant les abus constituées d'agonistes et d'agonistes/antagonistes d'opiacés
CA2974324A1 (fr) * 2015-01-28 2016-08-04 Zita S. Netzel Procedes et systemes d'administration de medicament

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Also Published As

Publication number Publication date
WO2019090125A3 (fr) 2020-04-02

Similar Documents

Publication Publication Date Title
US20190231707A1 (en) Transdermal drug delivery device for delivering opioids
CN1827107B (zh) 用丁丙诺啡实现持续止痛
CA2673856C (fr) Formes dosifiees de petit volume de medicament contenant du sufentanil s'administrant par voie trans-muqueuse orale pour le traitement de la douleur
JP6138196B2 (ja) 経粘膜剤形の投与のための貯蔵および投与デバイス
HUT69390A (en) Controlled, sustained release delivery system for smoking cessation
US20090035357A1 (en) Method of drug delivery using a transdermal device having a phase change material
AU2015209466B2 (en) Abuse and misuse deterrent transdermal systems
CN101406703A (zh) 降低了滥用可能的经皮止痛系统
JP2013523780A (ja) オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤
WO2019090125A2 (fr) Système d'administration de médicament transdermique anti-abus intelligent
KR20150096460A (ko) 경피 전달 시스템
US20150065822A1 (en) Systems and methods for addiction prevention and treatment
US20210060317A1 (en) Opioid overdose rescue device
CN104144685B (zh) 包括多孔微粒的透皮装置
US20220000773A1 (en) Self-reminding patch
US11369789B2 (en) Transdermal drug delivery system
CN115192511A (zh) 水溶性微针及其制备方法、微针贴片和透皮给药系统
TR2022013222A1 (tr) Naltrekson i̇çeren i̇n si̇tu jel oluşturan çözelti̇ler
Sherman et al. Corticotrophin-Releasing Hormone: Effects on Stress-Related Behavior in Rats

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 10.09.2020)

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18872285

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 18872285

Country of ref document: EP

Kind code of ref document: A2